Pila Pharma AB (publ) (STO:PILA)
Sweden
· Delayed Price · Currency is SEK 1.182
-0.064 (-5.14%)
At close: Mar 6, 2026
Pila Pharma AB Market Cap
Pila Pharma AB has a market cap or net worth of 54.00 million as of March 6, 2026. Its market cap has decreased by -46.63% in one year.
Market Cap
54.00M
Enterprise Value
38.10M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.18
Market Cap Chart
Since July 15, 2021, Pila Pharma AB's market cap has decreased from 144.39M to 54.00M, a decrease of -62.60%. That is a compound annual growth rate of -19.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 54.00M | -37.72% |
| Dec 30, 2025 | 86.69M | -14.78% |
| Dec 30, 2024 | 101.72M | 167.21% |
| Dec 29, 2023 | 38.07M | -23.60% |
| Dec 29, 2022 | 49.83M | -54.49% |
| Dec 30, 2021 | 109.48M | -24.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alzinova AB | 61.66M |
| AcouSort AB | 46.98M |
| Nanologica AB | 35.79M |
| 2cureX AB | 35.65M |
| Modus Therapeutics Holding AB | 35.39M |
| Spago Nanomedical AB | 83.36M |
| OncoZenge AB | 85.83M |
| Scandinavian ChemoTech AB | 88.33M |